|
Stephen Infante is a partner in our New York office who focuses on mergers and acquisitions and also practices in the areas of corporate governance, securities, finance, and private equity. His experience includes public and private acquisitions and divestitures, “going private” transactions, recapitalizations, and other leveraged transactions, minority investments, cross-border transactions and joint ventures, as well as representation of investment banks as financial advisors in M&A transactions.
He represents clients in a variety of industries including life sciences, software and technology, and communications and media.
Representative Matters
- Represented Kerr-McGee in its $18 billion merger with Anadarko Petroleum, in its defense and settlement of a proxy contest initiated by Carl C. Icahn and JANA Partners, in a $4 billion “Dutch” auction self tender offer and related spin-off of its chemicals business, and in its $3.4 billion acquisition of Westport Resources and related $650 million senior notes offering.
- Represented JLG Industries in its $3.2 billion merger with Oshkosh Truck Corporation.
- Represented Abbott Laboratories in its $3.7 billion acquisition of KOS Pharmaceuticals, Inc.
- Represented Charlesbank Capital Partners in its investments in Universal Technical Institute and Aurora Dairy Corporation, in its acquisition and sale of The GSI Group, in acquisitions of Zenith Products and The Horn Companies, and in its sale of American Tire Distributors.
- Represented Paramount Acquisition Corp., a healthcare-focused special purpose acquisition company, in its acquisition of ChemRx, an institutional pharmacy.
- Represented biotechnology company, Encysive Pharmaceuticals, in its exploration of strategic alternatives, which resulted in the sale of the company to Pfizer.
- Represented Intercel AG, an Austrian biotechnology company, in its acquisition of Iomai Inc., a publicly-traded vaccine developer.
|
|